Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$13.40 -0.16 (-1.18%)
At close: Oct 23, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Amortization of Deferred Charges (2024 - 2026)

Updated

Analysis

Syndax Pharmaceuticals (SNDX) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Syndax Pharmaceuticals 1.19 Bn -535.35 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 303,000.00
Mar 31, 2026 56,000.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 62,000.00
Jun 30, 2025 55,000.00
Mar 31, 2025 112,000.00
Dec 31, 2024 30,000.00
API Access

Syndax Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SNDX&period=max&api_key=YOUR_API_KEY